Hemotune focuses on controlling sepsis; the intense, and often life-threatening, response of the immune system to defend against pathogens and pathogen-derived proteins in the bloodstream. Although sepsis and septic shock are quite extreme manifestations of infection, every case of sepsis starts with the patient being exposed to pathogenic bacteria, viruses or fungi. For the moment in most countries, antibiotics can be used to control infection. However this is not without a price: antibiotic resistance is increasing worldwide, giving rise to multi-drug, or even pan-resistant organisms, signalling the need for alternative strategies against pathogens in common infections. Things that can be

In this year's Wyss Annual Event start ups within the Wyss Zurich incubator, old and new, came together to present their work and raise awareness about their technology. The Wyss Zurich is a joint accelerator of the University of Zurich and ETH Zurich (Swiss Federal Institute of Technology Zurich), which was made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. h.c. mult. Hansjörg Wyss. With the help of the Wyss Zurich and its provision of funding, infrastructure and overall support, research which would have otherwise been confined within university walls were able to be translated to life. The research can develop into viable companies designing products w